Opinion

Video

Retrospective Claims Data and Patient Reported-Outcomes from COMMANDS Trial in Lower-Risk MDS

Author(s):

Andrew Brunner, MD,Amy DeZern, MD, MHS

Amy DeZern, MD, MHS, discusses a retrospective study on healthcare claims for patients with MDS treated with luspatercept and reviews patient-reported outcomes from the COMMANDS trial.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Subscribe Now!

Latest CME

View All
Community Oncology Connections™: Case Discussions in TNBC…Navigating the Latest Advances and Impact of Disparities in Care | North Carolina
Video

Community Oncology Connections™: Case Discussions in TNBC…Navigating the Latest Advances and Impact of Disparities in Care | North Carolina

Apr 17th 2025 - May 23rd 2025

online-activity
View More
Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota
Video

Community Oncology Connections™: Community Oncologists’ Role in Selecting Optimal Oral SERD Treatment for HR+/HER2– Breast Cancer | Minnesota

Apr 17th 2025 - May 23rd 2025

online-activity
View More
18th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies
Video

18th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

Apr 8th 2025 - May 14th 2025

online-activity
View More
Related Content
Jamile M. Shammo, MD, Dr. Marjorie C. Barnett - Dr. Hau C. Kwaan Professor, professor, medicine (hematology and oncology), Northwestern University’s Feinberg School of Medicine
April 17th 2025

JAK Inhibitor Safety Is at the Heart of Treatment Selection in Myelofibrosis

Chandler Park, MD, medical oncologist, Norton Cancer Institute; Ann S. LaCasce, MD, MMSc, associate professor, medicine, lymphoma specialist, Dana-Farber Cancer Institute, Director, Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology
March 26th 2025

Strong Mentorship Opportunities Support the Next Generations of Women in Lymphoma: With Chandler Park, MD; and Ann S. LaCasce, MD, MMSc

DLBCL | Image Credit: © LASZLO – stock.adobe.com
April 14th 2025

Glofitamab Plus Chemo Wins European Approval for R/R DLBCL

Paul J. Shaughnessy, MD, medical director, Adult Blood and Marrow Stem Cell Transplant Program, Methodist Hospital
November 28th 2024

FDA Approval Insights: Obe-Cel in B-Cell Precursor ALL

BiTE-Associated AEs | Image Credit: © Katsyarina – stock.adobe.com
April 10th 2025

Multidisciplinary BiTE-Associated AE Education Increases the Safety of Outpatient Administration

Image Credit: © สุพัฒตรา แสนพลี – stock.adobe.com
April 9th 2025

Investigational Microbiotherapy MaaT033 Is Safe in Allo-HSCT Recipients